In Situ Quantitative Imaging of Plasma Membrane Stiffness in Live Cells Using a Genetically Encoded FRET Sensor

Anal Chem. 2024 May 28;96(21):8501-8509. doi: 10.1021/acs.analchem.4c00433. Epub 2024 May 8.

Abstract

Cell membrane stiffness is critical for cellular function, with cholesterol and sphingomyelin as pivot contributors. Current methods for measuring membrane stiffness are often invasive, ex situ, and slow in process, prompting the need for innovative techniques. Here, we present a fluorescence resonance energy transfer (FRET)-based protein sensor designed to address these challenges. The sensor consists of two fluorescent units targeting sphingomyelin and cholesterol, connected by a linker that responds to the proximity of these lipids. In rigid membranes, cholesterol and sphingomyelin are in close proximity, leading to an increased FRET signal. We utilized this sensor in combination with confocal microscopy to explore changes in plasma membrane stiffness under various conditions, including differences in osmotic pressure, the presence of reactive oxygen species (ROS) and variations in substrate stiffness. Furthermore, we explored the impact of SARS-CoV-2 on membrane stiffness and the distribution of ACE2 after attachment to the cell membrane. This tool offers substantial potential for future investigations in the field of mechanobiology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin-Converting Enzyme 2 / metabolism
  • Biosensing Techniques / methods
  • COVID-19 / virology
  • Cell Membrane* / chemistry
  • Cell Membrane* / metabolism
  • Cholesterol* / analysis
  • Cholesterol* / metabolism
  • Fluorescence Resonance Energy Transfer* / methods
  • Humans
  • Microscopy, Confocal / methods
  • Reactive Oxygen Species / analysis
  • Reactive Oxygen Species / metabolism
  • SARS-CoV-2*
  • Sphingomyelins* / analysis
  • Sphingomyelins* / metabolism

Substances

  • Sphingomyelins
  • Cholesterol
  • Reactive Oxygen Species
  • Angiotensin-Converting Enzyme 2